Status:
COMPLETED
Role of Salbutamol in the Management of Transient Tachypnea of the New Born
Lead Sponsor:
Khyber Teaching Hospital
Conditions:
TTN
Eligibility:
All Genders
1-28 years
Phase:
PHASE1
Brief Summary
Role of Salbutamol in the management of transient tachypnea of the new born
Detailed Description
Role of Salbutamol in the management of transient tachypnea of the new born Abstract: Background Transient tachypnea of the newborn (TTN) is a common respiratory disorder in the early neonatal period...
Eligibility Criteria
Inclusion
- Neonates with transient tachypnea
- \-
Exclusion
- age above 28 days
- Other diseases than transient tachypnea of the new born
Key Trial Info
Start Date :
August 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06921291
Start Date
August 1 2024
End Date
December 31 2024
Last Update
April 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Khyber Teaching Hospital Peshawar Pakistan
Timergara, KPK, Pakistan, 18300